Wendy Tomlinson is Chief Scientific Officer at Platelet Services. In this blog she talks about her career and how it is possible to pursue a

Unwanted effects of drug compounds on platelet function can include a risk of increased bleeding and thrombotic events, depending on whether inhibition or enhancement of

Tyrosine kinase inhibitors (TKIs) are widely used as a targeted strategy for cancer treatment. However, due to their broad kinase target spectrum, most TKIs inevitably